An upstate New York pharmaceutical sales representative was among three whistle-blowers to supply information to federal prosecutors leading to a $193 million settlement with makers of the Lidoderm ...

Watson Pharma intends to begin shipments of its generic version of Lidoderm in September 2013 per the terms of its settlement agreement with Endo. Watson believes it is entitled to a 180-day period of ...

SAN FRANCISCO (CN) - A federal judge on Thursday finalized two class action settlements worth $270 million, ending four years of litigation over an alleged antitrust conspiracy to keep a generic form ...

AUSTIN, TX—Arash Nafissi, DO, and colleagues of Hospital for Joint Disease, New York University, report that placing a topical Lidoderm patch provides an effective adjunct treatment in post-operative ...

Under the settlement agreement, the company inked a Deferred Prosecution Agreement (:DPA) with the United States Department of Justice. The duration of the DPA is up to 2 years and 6 months. In a ...

The drug maker added an amendment to a citizen petition it filed with the FDA in 2006 concerning the drug Lidoderm (lidocaine), a patch used to treat post-herpetic neuralgia, a painful condition ...

Endo Pharmaceuticals became the latest drugmaker to ink an off-label marketing settlement, paying $192.7 million to resolve charges it promoted pain patch Lidoderm for unapproved uses. According to a ...

PHILADELPHIA (Legal Newsline) – Endo Health Solutions Inc. and its subsidiary, Endo Pharmaceuticals, have agreed to a $171.9 million settlement with the federal government to resolve off-label ...

SAN FRANCISCO (CN) – Rejecting arguments that damages would be too arduous to calculate on a class-wide basis, a federal judge this week certified two classes in a multidistrict antitrust suit over ...

The US Department of Health and Human Services (HHS) has issued Endo Pharmaceuticals a subpoena regarding the promotion of its post-shingles pain patch Lidoderm. The subpoena requests documents from ...

September 28, 2010 (Las Vegas, Nevada) — The use of a transdermal lidocaine 5% patch (Lidoderm, Endo Pharmaceuticals) benefits patients who have undergone unilateral knee replacement surgery by ...

SAN FRANCISCO (MarketWatch) -- Endo Pharmaceutical Holdings Inc. after Tuesday's closing bell said that the Food and Drug Administration's Office of Generic Drugs has issued bioequivalence ...